159 related articles for article (PubMed ID: 9595136)
21. Successful discordant pancreatic islet xenotransplantation by prevention of primary nonfunction graft rejection and autoimmune disease recurrence.
Henretta J; Pittman K; McFadden T; Thomas F
Transplant Proc; 1994 Jun; 26(3):1133-4. PubMed ID: 8029859
[No Abstract] [Full Text] [Related]
22. Deoxyspergualin--a different and intriguing immunosuppressant.
Tufveson G; Gannedahl G
Transplant Proc; 1994 Oct; 26(5):3029-39. PubMed ID: 7940954
[No Abstract] [Full Text] [Related]
23. Effect of rapamycin on islet and skin xenograft survival.
Bobbio SA; Porter JG; Monaco AP
Transplant Proc; 1993 Aug; 25(4):2745-6. PubMed ID: 8356733
[No Abstract] [Full Text] [Related]
24. Mycophenolate mofetil's effect on accelerated heart allograft rejection and rejection markers in the rat.
Chen H; Qi S; Xu D; Wu J; Busque S; Daloze P
Transplant Proc; 1998 Jun; 30(4):1049-50. PubMed ID: 9636424
[No Abstract] [Full Text] [Related]
25. Prolongation of pig islet xenograft survival in rats by local immunosuppression with FK 506.
Tze WJ; Tai J; Cheung SS; Bissada N; Starzl TE
Transplant Proc; 1994 Apr; 26(2):777-8. PubMed ID: 7513471
[No Abstract] [Full Text] [Related]
26. Coadministration of malononitrilamides and tacrolimus induces tolerance in a rat skin allograft model.
Schorlemmer HU; Bartlett RR; Lindner JK; Kurrle R
Transplant Proc; 1999; 31(1-2):1184-8. PubMed ID: 10083529
[No Abstract] [Full Text] [Related]
27. Brequinar sodium and liver hemoperfusion in xenotransplantation.
Chastanet S; Cursio R; Gugenheim J; Baldini E; Chevallier A; Damais A; Charpentier B; Mouiel J
Transplant Proc; 1998 Aug; 30(5):2244-5. PubMed ID: 9723457
[No Abstract] [Full Text] [Related]
28. Lack of accommodation after long-term survival of hamster xenografts in rats.
Ribas Y; Molleví DG; Mestre M; Vidal A; Berenguer C; González R; Figueras J; Jaurrieta E; Mánezñez R
Transplant Proc; 1999 Sep; 31(6):2633-4. PubMed ID: 10500752
[No Abstract] [Full Text] [Related]
29. Extended skin allo- and xenograft survival in mice treated with rapamycin, antilymphocyte serum, and donor-specific bone marrow transfusion.
Hale DA; Gottschalk R; Fukuzaki T; Wood ML; Maki T; Monaco AP
Transplant Proc; 1996 Dec; 28(6):3269. PubMed ID: 8962269
[No Abstract] [Full Text] [Related]
30. KRP-203, a novel synthetic immunosuppressant, prolongs graft survival and attenuates chronic rejection in rat skin and heart allografts.
Shimizu H; Takahashi M; Kaneko T; Murakami T; Hakamata Y; Kudou S; Kishi T; Fukuchi K; Iwanami S; Kuriyama K; Yasue T; Enosawa S; Matsumoto K; Takeyoshi I; Morishita Y; Kobayashi E
Circulation; 2005 Jan; 111(2):222-9. PubMed ID: 15642767
[TBL] [Abstract][Full Text] [Related]
31. Extended and expanded studies of xenograft rejection in immunodeficient animals.
Thomas F; Araneda D; Henretta J; Pittman K; Marchman W
Transplant Proc; 1994 Jun; 26(3):1224-7. PubMed ID: 8029895
[No Abstract] [Full Text] [Related]
32. Prevention of heart allograft and kidney xenograft rejection by monoclonal antibody to CD45RB.
Zhang Z; Zhong R; Jiang J; Wang J; Garcia B; Le Feuvre C; White M; Stiller C; Lazarovits A
Transplant Proc; 1997; 29(1-2):1253. PubMed ID: 9123294
[No Abstract] [Full Text] [Related]
33. Cytidine potentiates the inhibitory effect of brequinar sodium on concordant cardiac xenograft rejection.
Catena M; Woo J; Valdivia LA; Celli S; Pan F; Fung JJ; Starzl TE; Thompson AW
Transplant Proc; 1994 Jun; 26(3):1288-9. PubMed ID: 8029911
[No Abstract] [Full Text] [Related]
34. Acute skin graft rejection can be prevented and treated in rat models by malononitrilamides.
Schorlemmer HU; Schwab W; Ruuth E; Kurrle R
Transplant Proc; 1996 Dec; 28(6):3048-50. PubMed ID: 8962182
[No Abstract] [Full Text] [Related]
35. Cardiac graft rejection in hypersensitized recipients: prevention of antibody response and graft rejection using brequinar sodium.
Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
Transplant Proc; 1993 Jun; 25(3 Suppl 2):65-6. PubMed ID: 8516948
[No Abstract] [Full Text] [Related]
36. Organ-specific tolerance induced by intrathymic injection of donor bone marrow cells and FK 506 or antilymphocyte serum in rat heart transplantation.
Matsuura T; Imanishi M; Hara Y; Tahara H; Kanda H; Kurita T
Transplant Proc; 1994 Aug; 26(4):1962-3. PubMed ID: 7520616
[No Abstract] [Full Text] [Related]
37. The prevention of accelerated cardiac allograft rejection in sensitized recipients after treatment with brequinar sodium.
Yasunaga C; Cramer DV; Chapman FA; Wang HK; Barnett M; Wu GD; Makowka L
Transplantation; 1993 Oct; 56(4):898-904. PubMed ID: 8212214
[TBL] [Abstract][Full Text] [Related]
38. Comparative efficacy of immunosuppressive drugs in xenografting.
Thomas FT; DeMasi RJ; Araneda D; Marchman W; Alqaisi M; Larkin EW; Condie RM; Carobbi A; Thomas JM
Transplant Proc; 1990 Jun; 22(3):1083-5. PubMed ID: 1693452
[No Abstract] [Full Text] [Related]
39. The new immunosuppressive malononitrilamide MNA 279 prolongs skin xenograft survival in a mouse-to-rat model.
Schorlemmer HU; Kurrle R
Transplant Proc; 1997 Dec; 29(8):3497-500. PubMed ID: 9414810
[No Abstract] [Full Text] [Related]
40. Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts.
Murase N; Fujisaki S; Tanabe M; Tsamandas AC; Todo S; Starzl TE; Demetris AJ
Transplant Proc; 1994 Jun; 26(3):1517-8. PubMed ID: 7518139
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
